RPL26

Across TCGA pan-cancer cohorts, RPL26 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated RPL26 data layer compared with 24 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher RPL26 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL26 expression acts as an unfavorable survival marker.

TGCT and UCEC are the cancer types where RPL26 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	DFS	Median	All	0.082	0.837	<.001	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RPL26–TGCT (DFS)

Open the TGCT breakdown →